On Tuesday, December 9th, 2014, Reed Smith Partner Barbara Binis and Jennifer Dubas, Vice President of Litigation & Risk at Endo Pharmaceuticals, will present "Strategically Addressing Alarming Trends in Drug and Med Litigation: Third Party Funding of Claims and Subrogation Actions By Health Insurers" at the American Conference Institute's 19th Annual Drug and Medical Device Litigation Conference.

Topics to be discussed include:

Third Party Funding of Products Liability Litigation

• Understanding the creative ways plaintiffs firms are using third parties to generate cases and further develop volume in litigation
  • Third party funding companies
  • Overseas call centers
  • Medical insurance companies
• Uncovering, identifying and responding to financial interests other then the allegedly injured plaintiffs: Determining whether this is going on in your litigation
  • Issuing subpoenas and conducting strategic discovery aimed at exposing the new volume of claims
  • Propounding discovery to ensure disclosure of contractual relationships between the respective parties

Subrogation Actions by Health Insurers Against Drug and Med Companies for Products Liability

• Overview of recent cases involving claims from third party payors seeking to recoup the cost of medical bills for alleged victims during products liability litigation
  • Spotlight on Blue Cross and the Actos litigation
  • Under the Affordable Care Act, can we expect to see more cases like this?
• Lessons learned from over a decade of subrogation claims in Canada: how are biopharmaceutical and medical device manufacturers successfully defending themselves there?